Bathi sadurunge bunga, pajak, lan amortisasi: mersana.com (MRSN)

Mersana Therapeutics (MRSN) develops high-precision molecules for the targeted delivery of toxins into tumors. The company's operations are protected by a global humanitarian consensus, which eliminates geopolitical risks. Revenues are based on the commercialization of ADCs for the treatment of lung and ovarian cancers. The GURU.Markets portal features a chart of absolute EBITDA dynamics, where the figure remains around 0.00.

MRSN Bathi operasional EBITDA Mersana Therapeutics, Inc. (23.11.2025 - 17.01.2026)

Ringkesan rincian data analitis Mersana Therapeutics (MRSN)

- kuotasi saiki lan rata-rata prakiraan nilai:

Kutipan saham Mersana Therapeutics|MRSN - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Mersana Therapeutics Inc|MRSN - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham Mersana Therapeutics|MRSN - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku mersana.com|MRSN - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Utang marang Ekuitas Mersana Therapeutics|MRSN - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Mersana|MRSN - Gunggung utang perusahaan|Utang-utang marang nilai buku Mersana Therapeutics Inc|MRSN - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Mersana Therapeutics|Koefisien jangkoan perantara mersana.com

- data bathi lan kelipatan valuasi:

MRSN - Bathi resik|Proyeksi bathi mangsa ngarep Mersana Therapeutics|MRSN - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Mersana|MRSN - Pangali PEG|Pangali EV/EBITDA Mersana|MRSN - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Mersana Therapeutics|MRSN - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan mersana.com|MRSN - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Mersana Therapeutics

- indikator pendapatan dodolan lan penghasilan bisnis:

MRSN - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan Mersana Therapeutics|MRSN - Rasio rega marang pendapatan|Rega forward marang dodolan Mersana Therapeutics, Inc.

Ringkesan analitik perusahaan:Mersana Therapeutics

For Mersana Therapeutics (MRSN), given its high dependence on oncology clinical trial outcomes, EBITDA analysis is critical for assessing financial viability amidst binary risks. This metric isolates net operating cash flow by excluding the impact of debt service and taxes, allowing investors to detect revenue degradation before a deep crisis occurs.

Pesaing Mersana Therapeutics (MRSN)

MRUS - Bathi operasional sadurunge ngurangi amortisasi|IMMP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Anixa Biosciences|Atossa Pharma (ATOS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Context Therapeutics Inc|BCTX (BriaCell Therapeutics Corp.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi essapharma.com EPIX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi qtimaging.com (QTI)